Basic Information
| RNALocate ID: | RLID-D:11000339 |
| RNA Symbol: | hsa-miR-223-3p |
| Localization: | Microvesicle |
RNA Information
| RNA Name: | hsa-miR-223-3p |
| RNA ID: | miRBase:MIMAT0000280 |
| RNA Category: | miRNA |
| Species: | Homo sapiens |
Localization Information
| Tissue/Cell Line: | Fibroblasts|Mesenchymal stem cells |
| Database: | EVmiRNA |
Other Subcellular Localization
| RNALocate ID | Localization | Tissue/Cell line | PubMed ID |
| RLID:01001680 | Endoplasmic reticulum membrane | Cortical tissue | 32451872 |
| RLID:11001553 | Exosome | Dendritic cells (in vitro differentiated Langerhans cells)|Healthy plasma|Mast cells (HMC-1 cell line)|PCa patient plasma | 25267620 |
| RLID:11001554 | Exosome | Macrophages | 27396686 |
| RLID:11001555 | Exosome | B cell line (Raji)|Primary dendritic cells | 21505438 |
| RLID:11001556 | Exosome | Breast cancer cell lines (HEK-293T|MDA-MB-231|SKBR3)|Macrophages | 21939504 |
| RLID:11001557 | Exosome | Ovarian follicular fluid | 22116803 |
| RLID:11001558 | Exosome | Breast milk | 22211110 |
| RLID:11001559 | Exosome | Brain tissue | 23382797 |
| RLID:11001560 | Exosome | Plasma | 23663360 |
| RLID:11001561 | Exosome | Human mast cell line (HMC-1) | 24009880 |
| RLID:11001562 | Exosome | Plasma | 24130905 |
| RLID:11001563 | Exosome | B cell lymphoma cell lines|EBV-transformed lymphoblastoid B cells | 25242326 |
| RLID:11001564 | Exosome | Saliva | 25376581 |
| RLID:11001565 | Microvesicle | Liver resident stem cells|Mesenchymal stem cells | 20668554 |
| RLID:11001566 | Microvesicle | Plasma | 23077538 |
| RLID:11001567 | Microvesicle | Follicular fluid | 23666971 |
| RLID-D:11000065 | Exosome | Blood|Breast milk|Mast cells |
ncRNA Disease Information
| Resource | RNA Symbol | Disease | Link |
| MNDR | hsa-miR-223-3p | Inflammatory bowel disease | MNDR-E-MI-31154 |
| MNDR | hsa-miR-223-3p | Splenic marginal zone lymphoma | MNDR-E-MI-31155 |
| MNDR | hsa-miR-223-3p | Multiple sclerosis chronic progressive | MNDR-E-MI-31156 |
| MNDR | hsa-miR-223-3p | Oral squamous cell carcinoma | MNDR-E-MI-31157 |
| MNDR | hsa-miR-223-3p | Medulloblastoma | MNDR-E-MI-31158 |
| MNDR | hsa-miR-223-3p | Small intestinal neuroendocrine tumor | MNDR-E-MI-31159 |
| MNDR | hsa-miR-223-3p | Lymphoma | MNDR-E-MI-31160 |
| MNDR | hsa-miR-223-3p | Lymphoma non-hodgkin | MNDR-E-MI-31161 |
| MNDR | hsa-miR-223-3p | Estrogen-receptor positive breast cancer | MNDR-E-MI-31162 |
| MNDR | hsa-miR-223-3p | Estrogen-receptor negative breast cancer | MNDR-E-MI-31163 |
| MNDR | hsa-miR-223-3p | Progesterone-receptor positive breast cancer | MNDR-E-MI-31164 |
| MNDR | hsa-miR-223-3p | Progesterone-receptor negative breast cancer | MNDR-E-MI-31165 |
| MNDR | hsa-miR-223-3p | Acute promyelocytic leukemia | MNDR-E-MI-31166 |
| MNDR | hsa-miR-223-3p | Breast cancer luminal | MNDR-E-MI-31167 |
| MNDR | hsa-miR-223-3p | Precursor cell lymphoblastic leukemia-lymphoma | MNDR-E-MI-31168 |
| MNDR | hsa-miR-223-3p | Hereditary neutrophilia | MNDR-E-MI-31169 |
| MNDR | hsa-miR-223-3p | Small intestine cancer | MNDR-E-MI-31170 |
| MNDR | hsa-miR-223-3p | Dermatomyositis | MNDR-E-MI-31171 |
| MNDR | hsa-miR-223-3p | Prostate cancer | MNDR-E-MI-31172 |
| MNDR | hsa-miR-223-3p | Chronic lymphocytic leukemia | MNDR-E-MI-31173 |
| MNDR | hsa-miR-223-3p | Gastric cancer | MNDR-E-MI-31174 |
| MNDR | hsa-miR-223-3p | Gastric lymphoma | MNDR-E-MI-31175 |
| MNDR | hsa-miR-223-3p | Alzheimer disease | MNDR-E-MI-31176 |
| MNDR | hsa-miR-223-3p | Intracranial aneurysm | MNDR-E-MI-31177 |
| MNDR | hsa-miR-223-3p | Bladder cancer | MNDR-E-MI-31178 |
| MNDR | hsa-miR-223-3p | Esophageal carcinoma | MNDR-E-MI-31179 |
| MNDR | hsa-miR-223-3p | Sarcoma | MNDR-E-MI-31180 |
| MNDR | hsa-miR-223-3p | Dysautonomia familial | MNDR-E-MI-31181 |
| MNDR | hsa-miR-223-3p | Polycystic ovary syndrome | MNDR-E-MI-31182 |
| MNDR | hsa-miR-223-3p | Duchenne muscular dystrophy | MNDR-E-MI-31183 |
| MNDR | hsa-miR-223-3p | Primary biliary cirrhosis | MNDR-E-MI-31184 |
| MNDR | hsa-miR-223-3p | Leukemia | MNDR-E-MI-31185 |
| MNDR | hsa-miR-223-3p | Huntington disease | MNDR-E-MI-31186 |
| MNDR | hsa-miR-223-3p | Chorea | MNDR-E-MI-31187 |
| MNDR | hsa-miR-223-3p | Cardiovascular disease | MNDR-E-MI-31188 |
| MNDR | hsa-miR-223-3p | Lung cancer | MNDR-E-MI-31189 |
| MNDR | hsa-miR-223-3p | Kawasaki disease | MNDR-E-MI-31190 |
| MNDR | hsa-miR-223-3p | Down syndrome | MNDR-E-MI-31191 |
| MNDR | hsa-miR-223-3p | Parkinson disease | MNDR-E-MI-31192 |
| MNDR | hsa-miR-223-3p | Basal-like breast cancer | MNDR-E-MI-31193 |
| MNDR | hsa-miR-223-3p | Thyroid cancer | MNDR-E-MI-31194 |
| MNDR | hsa-miR-223-3p | Pancreatic cancer | MNDR-E-MI-31195 |
| MNDR | hsa-miR-223-3p | HCV | MNDR-E-MI-31196 |
| MNDR | hsa-miR-223-3p | Melanoma | MNDR-E-MI-31197 |
| MNDR | hsa-miR-223-3p | Rectum adenocarcinoma | MNDR-E-MI-31198 |
| MNDR | hsa-miR-223-3p | Nephroblastoma | MNDR-E-MI-31199 |
| MNDR | hsa-miR-223-3p | Colon cancer | MNDR-E-MI-31200 |
| MNDR | hsa-miR-223-3p | Essential thrombocythemia | MNDR-E-MI-31201 |
| MNDR | hsa-miR-223-3p | Ischemic attack transient | MNDR-E-MI-31202 |
| MNDR | hsa-miR-223-3p | Colon adenocarcinoma | MNDR-E-MI-31203 |
| MNDR | hsa-miR-223-3p | Multiple sclerosis relapsing-remitting | MNDR-E-MI-31204 |
| MNDR | hsa-miR-223-3p | Ovarian cancer | MNDR-E-MI-31205 |
| MNDR | hsa-miR-223-3p | Asthma | MNDR-E-MI-31206 |
| MNDR | hsa-miR-223-3p | Pulmonary tuberculosis | MNDR-E-MI-31207 |
| MNDR | hsa-miR-223-3p | Carcinoma ductal breast | MNDR-E-MI-31208 |
| MNDR | hsa-miR-223-3p | Glioblastoma | MNDR-E-MI-31209 |
| MNDR | hsa-miR-223-3p | Glioma | MNDR-E-MI-31210 |
| MNDR | hsa-miR-223-3p | Nemaline myopathy | MNDR-E-MI-31211 |
| MNDR | hsa-miR-223-3p | Amyotrophic lateral sclerosis | MNDR-E-MI-31212 |
| MNDR | hsa-miR-223-3p | Epilepsy temporal lobe | MNDR-E-MI-31213 |
| MNDR | hsa-miR-223-3p | Osteosarcoma | MNDR-E-MI-31214 |
| MNDR | hsa-miR-223-3p | Liposarcoma | MNDR-E-MI-31215 |
| MNDR | hsa-miR-223-3p | Coronary artery disease | MNDR-E-MI-31216 |
| MNDR | hsa-miR-223-3p | Inclusion body myositis | MNDR-E-MI-31217 |
| MNDR | hsa-miR-223-3p | Pancreatic ductal adenocarcinoma | MNDR-E-MI-31218 |
| MNDR | hsa-miR-223-3p | Meningioma | MNDR-E-MI-31219 |
| MNDR | hsa-miR-223-3p | Liver cancer | MNDR-E-MI-31220 |
| MNDR | hsa-miR-223-3p | Uterine cancer | MNDR-E-MI-31221 |
| MNDR | hsa-miR-223-3p | Cervical adenocarcinoma | MNDR-E-MI-31222 |
| MNDR | hsa-miR-223-3p | Gastric adenocarcinoma | MNDR-E-MI-31223 |
| MNDR | hsa-miR-223-3p | Pituitary adenoma | MNDR-E-MI-31224 |
| MNDR | hsa-miR-223-3p | Lung squamous cell carcinoma | MNDR-E-MI-31225 |
| MNDR | hsa-miR-223-3p | Lung adenocarcinoma | MNDR-E-MI-31226 |
| MNDR | hsa-miR-223-3p | Thyroid carcinoma | MNDR-E-MI-31227 |
| MNDR | hsa-miR-223-3p | Bladder urothelial carcinoma | MNDR-E-MI-31228 |
| MNDR | hsa-miR-223-3p | Pancreatic adenocarcinoma | MNDR-E-MI-31229 |
| MNDR | hsa-miR-223-3p | Carcinoma renal cell | MNDR-E-MI-31230 |
| MNDR | hsa-miR-223-3p | Kidney renal papillary cell carcinoma | MNDR-E-MI-31231 |
| MNDR | hsa-miR-223-3p | Clear cell renal cell carcinoma | MNDR-E-MI-31232 |
| MNDR | hsa-miR-223-3p | Biliary tract cancer | MNDR-E-MI-31233 |
| MNDR | hsa-miR-223-3p | Myelofibrosis | MNDR-E-MI-31234 |
| MNDR | hsa-miR-223-3p | Esophageal cancer | MNDR-E-MI-31235 |
| MNDR | hsa-miR-223-3p | Liver cirrhosis | MNDR-E-MI-31236 |
| MNDR | hsa-miR-223-3p | HIV | MNDR-E-MI-31237 |
| MNDR | hsa-miR-223-3p | Lung small cell carcinoma | MNDR-E-MI-31238 |
| MNDR | hsa-miR-223-3p | Head and neck squamous cell carcinoma | MNDR-E-MI-31239 |
| MNDR | hsa-miR-223-3p | Fibromyalgia | MNDR-E-MI-31240 |
| MNDR | hsa-miR-223-3p | Breast invasive carcinoma | MNDR-E-MI-31241 |
| MNDR | hsa-miR-223-3p | Juvenile rheumatoid arthritis | MNDR-E-MI-31242 |
| MNDR | hsa-miR-223-3p | Hepatocellular carcinoma | MNDR-E-MI-31243 |
| MNDR | hsa-miR-223-3p | Embryonal cancer | MNDR-E-MI-31244 |
| MNDR | hsa-miR-223-3p | B-cell lymphoma | MNDR-E-MI-31245 |
| MNDR | hsa-miR-223-3p | Rheumatoid arthritis | MNDR-E-MI-31246 |
| MNDR | hsa-miR-223-3p | T-cell leukemia | MNDR-E-MI-31247 |
| MNDR | hsa-miR-223-3p | Malignant pleural mesothelioma | MNDR-E-MI-31248 |
| MNDR | hsa-miR-223-3p | Chronic kidney disease | MNDR-E-MI-31249 |
| MNDR | hsa-miR-223-3p | Periodontitis | MNDR-E-MI-31250 |
| MNDR | hsa-miR-223-3p | Chronic fatigue syndrome | MNDR-E-MI-31251 |
| MNDR | hsa-miR-223-3p | Chronic myeloid leukemia | MNDR-E-MI-31252 |
| MNDR | hsa-miR-223-3p | Hodgkin lymphoma | MNDR-E-MI-31253 |
| MNDR | hsa-miR-223-3p | Burkitt lymphoma | MNDR-E-MI-31254 |
| MNDR | hsa-miR-223-3p | Dementia vascular | MNDR-E-MI-31255 |
| MNDR | hsa-miR-223-3p | Neuromyelitis optica | MNDR-E-MI-31256 |
| MNDR | hsa-miR-223-3p | Psoriasis | MNDR-E-MI-31257 |
| MNDR | hsa-miR-223-3p | Skin cutaneous melanoma | MNDR-E-MI-31258 |
| MNDR | hsa-miR-223-3p | Skin melanoma | MNDR-E-MI-31259 |
| MNDR | hsa-miR-223-3p | Acute myelocytic leukemia | MNDR-E-MI-31260 |
| MNDR | hsa-miR-223-3p | Colorectal cancer | MNDR-E-MI-31261 |
| MNDR | hsa-miR-223-3p | Multiple myeloma | MNDR-E-MI-31262 |
| MNDR | hsa-miR-223-3p | Acute lymphocytic leukemia | MNDR-E-MI-31263 |
| MNDR | hsa-miR-223-3p | Esophageal squamous cell carcinoma | MNDR-E-MI-31264 |
| MNDR | hsa-miR-223-3p | Nasopharyngeal cancer | MNDR-E-MI-31265 |
| MNDR | hsa-miR-223-3p | Chronic kidney disease-mineral and bone disorder | MNDR-E-MI-31266 |
| MNDR | hsa-miR-223-3p | Epstein-barr virus infections | MNDR-E-MI-31267 |
| MNDR | hsa-miR-223-3p | Subarachnoid hemorrhage traumatic | MNDR-E-MI-31268 |
| MNDR | hsa-miR-223-3p | Sarcopenia | MNDR-E-MI-31269 |
| MNDR | hsa-miR-223-3p | Stroke lacunar | MNDR-E-MI-31270 |
RNA Interaction Information
| Resource | RNA Symbol | Species | Link | RNALocate ID |
| RNAInter | ABCB1 | Homo sapiens | RR00022781 |
TOP